Hypercalcemia Treatment Market, By Drug Type (Bisphosphonates (Clodronate, Etidronate, Ibandronate, Pamidronate, Zoledronic, Acid), Calcitonin, Glucocorticoids, Denosumab, Calcimimetics), By Distribution Channel (Hospitals, Clinics, Independent Pharmacy & Drug Stores),and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 10,696.6 million in 2021 and is expected to exhibit a CAGR of 11.7% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights
Hypercalcemia, also known as hyperinsulimia or hypercalcemia, is a medical condition in which calcium level in body is above normal. This can also lead to kidney stones. High levels of calcium in the blood increase the risk of developing cancers of the kidney, breast, colon, bladder, leukemia and skin cancer. People with hypercalcemia are more likely to develop some cancers.
Get FREE Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/3504
Bayer Pharma AG, Sun Pharmaceutical Industries Ltd., Pfizer Inc., Mylan N.V., Amgen Inc., Novartis AG, Cipla Inc., Dr. Reddy’s Laboratories Ltd., and XOMA Corporation.
Key Market Drivers:
Growing prevalence of hypercalcemia is driving growth of the hypercalcemia treatment market. According to the U.S. National Library of Medicine, The prevalence of hypercalcemia in the general population is approximately 1% to 2%. Most of the cases (90%) of hypercalcemia are due to primary hyperparathyroidism and malignancy-associated hypercalcemia. The prevalence of primary hyperparathyroidism in the general population ranges from 0.2% to 0.8% and increases with age.
Increasing prevalence of cancer is another major fostering growth of the market. According to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in 2018. Moreover, increasing healthcare expenditure is again stimulating growth of the market.
Covid-19 Impact Analysis
The flare-up of novel Covid-19 has had severe impact around the world and made huge impact on economy with its spread. The medical care industry was one of the most terribly affected industry. There was delay in treatment for cancer patient due to travel restriction. However, many pharma companies are experiencing positive growth due to the growing demand for drug and medical device. This is encouraging manufacturers to increase the production capacity and supply around the globe.
Get PDF Brochure with Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/3504
The hypercalcemia treatment market is expected to exhibit a CAGR of 11.7 % over the forecast period due to growing awareness regarding hypercalcemia and increasing healthcare expenditure.
North America is expected to witness significant growth over the forecast period increasing launch of new drug for the treatment of hypercalcemia by key players. For instance, in Feburary 2017, Amgen announced that the U.S. Food and Drug Administration (FDA) has approved Parsabiv™ (etelcalcetide) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.
Reasons to Purchase this Report
• Current and future of global Hypercalcemia Treatment market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Hypercalcemia Treatment Market Size Analysis
11.6 COVID-19 Outbreak: Hypercalcemia Treatment Industry Impact
Chapter 2 Global Hypercalcemia Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Hypercalcemia Treatment (Volume and Value) by Type
2.3 Global Hypercalcemia Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Hypercalcemia Treatment Sales, Consumption, Export, Import by Regions
Chapter 5 North America Hypercalcemia Treatment Market Analysis
Chapter 6 East Asia Hypercalcemia Treatment Market Analysis
Chapter 7 Europe Hypercalcemia Treatment Market Analysis
Chapter 8 South Asia Hypercalcemia Treatment Market Analysis
Chapter 9 Southeast Asia Hypercalcemia Treatment Market Analysis
Chapter 10 Middle East Hypercalcemia Treatment Market Analysis
Chapter 11 Africa Hypercalcemia Treatment Market Analysis
Chapter 12 Oceania Hypercalcemia Treatment Market Analysis
Chapter 13 South America Hypercalcemia Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Hypercalcemia Treatment Business
Chapter 15 Global Hypercalcemia Treatment Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027